Clinical Trials Logo

Flu Vaccine clinical trials

View clinical trials related to Flu Vaccine.

Filter by:
  • None
  • Page 1

NCT ID: NCT05869968 Recruiting - Clinical trials for Spinal Cord Injuries

SCIVAX: Biomarkers of Immune Dysfunction and Vaccine Responsiveness in Chronic SCI

SCIVAX
Start date: March 31, 2023
Phase:
Study type: Observational

The purpose of this observational research study is to better understand immune responses to vaccines against viruses (influenza or SARS-CoV2). The goal is to determine any differences in immune responses to vaccines in uninjured people and in people living with spinal cord injuries, who are typically at increased risk of infections.

NCT ID: NCT04579588 Recruiting - Clinical trials for Corona Virus Infection

Understanding Immunity to the Flu Vaccine in COVID-19 Patients

Start date: October 29, 2020
Phase:
Study type: Observational

The purpose of this study is to measure immunity to the flu vaccine over time in patients who had COVID-19. Adults who have been diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.

NCT ID: NCT04077424 Completed - Flu Vaccine Clinical Trials

Senescent Immunity in Elders and Vaccine Responses (SILVER)

Start date: October 21, 2019
Phase: Phase 4
Study type: Interventional

To study the effects of age on the immune system's response to flu vaccine and to study the connection between the immune system and physical and cognitive changes associated with aging.